Caxton Associates (New York)’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,563
Closed -$2.15M 611
2021
Q2
$2.15M Buy
4,563
+3,254
+249% +$1.94M 0.24% 35
2021
Q1
$955K Buy
+1,309
New +$1.31M 0.09% 71
2020
Q3
Sell
-781
Closed -$1.7M 526
2020
Q2
$1.7M Buy
+781
New +$1.88M 0.15% 58
2019
Q3
Sell
-2,373
Closed -$3.95M 554
2019
Q2
$3.95M Buy
+2,373
New +$4.21M 0.48% 39

Other funds holding VXX

Caxton Associates (New York)'s VXX Position: Q2 2021 in Review

Caxton Associates (New York) sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2021, closing a stake of 27 shares — an estimated $16.1K sold.

Caxton Associates (New York) first reported a position in VXX in Q1 2021 and held it in 1 quarter. The position peaked at $19K in Q1 2021. 114 funds tracked by Wall St. Rank hold VXX as of Q2 2021.

  • Caxton Associates (New York) reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q2 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 27 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2021, an estimated $16.1K.
  • Caxton Associates (New York) first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $19K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.